RS
EW icon

Robeco Schweiz’s Edwards Lifesciences EW Stock Holding History

Robeco Schweiz’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.5M Buy
+16,529
New +$1.38M 0.02% 123
2018
Q2 		– Sell
-936
Closed -$44K – 180
2018
Q1 		$44K Sell
936
-657
-41% -$28.5K ﹤0.01% 174
2017
Q4 		$61K Buy
+1,593
New +$58.5K ﹤0.01% 172

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Robeco Schweiz's EW Position: Q2 2026 in Review

Robeco Schweiz opened a new position in Edwards Lifesciences (EW) in Q2 2026: 16,529 shares worth $1.5M. The stake represents 0.02% of the portfolio and ranks #123 among its holdings. This is a return to the name: Robeco Schweiz previously reported a position in EW as recently as Q1 2018.

Robeco Schweiz first reported a position in EW in Q4 2017 and has held it in 3 quarters since. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Robeco Schweiz held 16,529 shares of Edwards Lifesciences worth $1.5M as of Q2 2026.
  • Edwards Lifesciences was a new Robeco Schweiz position in Q2 2026.
  • Edwards Lifesciences made up 0.02% of Robeco Schweiz's portfolio in Q2 2026, its #123 holding.
  • Robeco Schweiz first reported a position in Edwards Lifesciences in Q4 2017 and has held it in 3 quarters since.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Robeco Schweiz's 13F filing for Q2 2026, filed 28 Jul 2026.